Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location-Reference-Cited by-同舟云学术

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

Published:2003-05 Issue:5 Volume:41 Page:2176-2179
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Pfaller M. A.¹²,Messer S. A.¹,Boyken L.¹,Tendolkar S.¹,Hollis R. J.¹,Diekema D. J.¹³

Affiliation:

1. Departments of Pathology

2. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa 52242

3. Medicine, Roy J. and Lucille A. Carver College of Medicine

Abstract

ABSTRACT We examined the susceptibilities to fluconazole of 559 bloodstream infection isolates of Candida glabrata and grouped the isolates by patient age and geographic location within the United States. Susceptibility of C. glabrata to fluconazole was lowest in the Pacific (44%) and East South Central (47%) regions and was highest in the West South Central region (82%) (regions are as designated by the U.S. Bureau of the Census). Isolates from pediatric patients were virtually all susceptible to fluconazole, whereas the highest frequency of resistance was observed in isolates from patients 16 to 64 years of age.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.41.5.2176-2179.2003

Reference26 articles.

1. Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis.24:1122-1128.

2. Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland

3. Baddley, J. W., A. M. Smith, S. A. Moser, and P. G. Pappas. 2001. Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital. Diagn. Microbiol. Infect. Dis.39:199-201.

4. Baran, J., B. Muckatira, and R. Khatib. 2001. Candidemia before and after the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand. J. Infect. Dis.33:137-139.

5. Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions;Expert Opinion on Drug Safety;2021-06-01

2. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016;Open Forum Infectious Diseases;2019-03

3. Candida Prophylaxis;Infectious Disease and Pharmacology;2019

4. Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes;Frontiers in Microbiology;2018-07-13

5. Candida glabrata’s Genome Plasticity Confers a Unique Pattern of Expressed Cell Wall Proteins;Journal of Fungi;2018-06-05